GeneDx Holdings Peer Comparison

$85.98

$-1.41 (-1.61%)

As on 04-Sep-2026 16:00EDT

Market cap

$2,575 Mln

Revenue (TTM)

$454 Mln

P/E Ratio

--

P/B Ratio

10.9

Div. Yield

0 %

Edit

	GeneDx Holdings	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Hims Hers Health Inc (HIMS)	Chemed Corp (CHE)
Market cap ($ Mln)	2,575	12,015	10,082	6,491	6,794
Revenue ($ Mln)	454	6,206	5,487	2,578	2,595
Net Profit ($ Mln)	-106.36	621.00	378.70	-142.03	274.99
Net Margin (%)	-23.40	10.01	6.90	-5.51	10.60
RoE (%)	-38.51	16.23	16.18	-32.84	30.39
Price to Earnings	--	20.33	27.11	--	26.15
Price-To-Book	10.89	4.60	4.14	20.48	8.25

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	GeneDx Holdings	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Hims Hers Health Inc (HIMS)	Chemed Corp (CHE)
Operating Revenue	454.43	6,206.10	5,486.71	2,578.11	2,595.00
Cost of Revenue	144.53	1,733.50	4,710.80	910.53	1,805.04
Gross Profit	298.17	5,680.80	799.45	1,733.38	758.34
Operating Expenses	370.51	3,421.70	308.52	1,760.25	440.80
Operating Profit (EBIT)	-60.61	1,117.00	467.39	-92.67	349.19
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-106.30	1,027.90	498.93	-163.61	369.16
Provision for Tax	1.10	210.30	119.90	-21.58	94.17
Profit after Tax (Net Income)	-106.36	621.00	378.70	-142.03	274.99
Minority Interest	0.00	-212.30	-0.33	0.00	0.00
Consolidated Profit	0.00	271.90	0.00	0.00	140.99

Liabilities ($ Mln)

	GeneDx Holdings	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Hims Hers Health Inc (HIMS)	Chemed Corp (CHE)
Shareholder's Funds	244.22	2,597.70	2,441.69	324.07	830.51
Minority Interest	0.00	-212.30	-0.33	0.00	0.00
Non-Current Liabilities	162.64	3,123.00	2,419.29	1,821.51	429.23
Current Liabilities	74.63	873.40	884.80	1,483.23	319.85
Total Liabilities	570.19	7,089.70	5,462.97	2,154.71	1,640.01

Assets ($ Mln)

	GeneDx Holdings	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Hims Hers Health Inc (HIMS)	Chemed Corp (CHE)
Non-Current Assets	235.13	6,416.50	4,677.91	2,244.20	1,288.35
Current Assets	246.36	1,041.00	1,071.49	1,384.61	291.24
Total Assets	570.19	7,089.70	5,462.97	2,154.71	1,640.01
Total Debt*	167.40	2,842.30	2,250.35	1,546.24	329.09
Net Current Assets	171.73	167.60	186.69	0.00	0.00

Cashflow ($ Mln)

	GeneDx Holdings	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Hims Hers Health Inc (HIMS)	Chemed Corp (CHE)
Cash From Operating Activities	33.28	1,175.60	564.27	300.01	388.27
Cash Flow from Investing Activities	-61.52	-762.80	-513.18	-1,024.96	-59.34
Cash from Financing Activities	48.03	-433.00	-11.81	729.62	-432.77
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	GeneDx Holdings	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Hims Hers Health Inc (HIMS)	Chemed Corp (CHE)
ROCE (%)	-5.12	11.40	6.75	11.94	22.16
ROE (%)	-38.51	16.23	16.18	-32.84	30.39
ROA (%)	-19.49	7.77	6.15	-3.97	14.28
EBIT Margin (%)	-22.73	18.59	9.24	-6.35	14.08
Net Margin (%)	-23.40	10.01	6.90	-5.51	10.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	GeneDx Holdings	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Hims Hers Health Inc (HIMS)	Chemed Corp (CHE)
Revenue Growth (%)	25.42	9.47	18.89	28.04	3.31
EBIT Growth (%)	-2,378.58	16.43	17.37	-217.51	-6.25
Net Profit Growth (%)	-7,664.51	18.81	17.32	-173.36	-5.29
EPS Growth (%)	-14,232.98	20.05	15.72	-179.07	1.50
Book Value Growth (%)	-11.75	16.44	19.22	-36.19	-24.60

Valuation Ratios

	GeneDx Holdings	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Hims Hers Health Inc (HIMS)	Chemed Corp (CHE)
Price / Earnings	-166.38	19.12	30.03	62.76	22.57
Price / Book Value	11.35	4.60	4.63	20.48	8.25
Dividend Yield (%)	--	0.62	--	0.00	0.46
EV/EBITDA	524.92	9.72	24.49	-92.05	15.92
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	GeneDx Holdings	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Hims Hers Health Inc (HIMS)	Chemed Corp (CHE)
Debt to Equity	0.40	1.00	0.06	0.00	0.00
Short term debt to equity ratio	0.02	0.02	0.05	0.04	0.09
Current Ratio	3.30	1.19	1.21	0.93	0.91
Quick Ratio	3.06	1.19	1.21	0.87	0.89
Interest Coverage	-34.62	9.18	65.04	--	77.54

Operating Efficiency Ratios

	GeneDx Holdings	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Hims Hers Health Inc (HIMS)	Chemed Corp (CHE)
Debtors to sales (%)	18.40	11.07	12.19	14.56	7.27
Asset Turnover	0.83	0.78	0.89	0.72	1.35
Receivable days	47.84	37.48	43.58	2.97	25.53
Inventory Days	34.73	--	--	53.56	1.62
Payable days	14.70	250.68	8.42	69.71	10.06
Cash Conversion Cycle	67.87	--	--	-13.17	17.10

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly